Max Access Solutions

An access model that puts patients first

Max Access Solutions is our innovative, patient-centered model for delivering cancer treatment to those in need. Through the program, launched in 2017, we connect people facing cancer in countries where treatment is not locally available to high-impact medicines, qualified medical professionals, and essential support services.

This work is made possible through partnerships with local physicians, ministries of health, other non-governmental organizations, patient organizations, and medicine manufacturers. Our partner physicians play a vital role in receiving the medication at the local level, enrolling patients into the program, and providing the individual care each patient needs.

Max Access Solutions is meant to bridge access to treatment in underserved areas, with a focus on low- and middle-income countries, until local access channels can be put in place.

  • 35K+

    patients provided access to medication and/or support services each year

  • 80+

    countries where medication access and/or support services are provided

  • 15

    medicines provided

Our Cancer Programs

For over 25 years, we’ve developed our cancer programs and expanded our partnerships to reach cancer patients in more than 80 low- and middle-income countries. We now offer a wide portfolio of life-extending medications for multiple disease areas and growing.

View all drugs and diseases in our programs

“The access to drugs, at no cost, has not only helped me financially but also enhanced my overall well-being. This has enabled me to sustain my occupation as a farmer, which demands immense endurance and physical strength. As a patient facing financial constraints, the provision of such vital medication is invaluable, and I cannot express enough gratitude to The Max Foundation, [the pharmaceutical company], and my treating physicians for facilitating access to this treatment.”

– Serali, a farmer, father, and grandfather from Nepal living with chronic myeloid leukemia

Latest Developments

  • CEO Pat Garcia-Gonzalez was interviewed by The Video Journal of Hematology and Hematological Oncology

    Interviews with VJHemOnc

    At the 13th Annual SOHO Meeting in Houston (Sept 3–6, 2025), Pat Garcia-Gonzalez, CEO of The Max Foundation presented data from our access to CML treatment program, including a treatment free remission support program we have implemented across low-and middle-income countries. After her presentation, she was interviewed by The Video Journal of Hematology and Hematological….

  • Pat's birthday

    Acting with humanity – donating my birthday – supporting cancer patients in Nepal

    Watch webinar on “Overcoming Barriers to Pediatric Cancer Care in Nepal” Last October I had the privilege of visiting Patan Hospital in Nepal on behalf of The Max Foundation. Right then, I knew I would dedicate my next birthday to supporting people in need of cancer treatment in the country by covering the cost of diagnostics….

  • Act With Humanity

    March 9 marks the devastating anniversary of the day my stepson Max died after a three-year battle with cancer. Max was 17 years old. I have dedicated most of the last 34 years to galvanizing the global community to help families avoid the suffering of the premature loss of their loved one. In the process,….

Overcoming Barriers to Access

Improving health outcomes for people living with cancer is about more than medication. We provide access to psychosocial support, transportation assistance, adherence monitoring, and more to ensure patient needs are handled individually and holistically.

Learn More
2024 M&E Report